Profile
Thomas Cerny is currently a Director at ProteoMediX AG and TOLREMO therapeutics AG, and the President of Swiss Cancer League.
He was previously a Director at THERAMetrics holding AG from 2009 to 2011.
Prior to his current positions, he was the Head-Oncology at the University of St. Gallen starting in 2009.
He holds a doctorate degree from the University of Bern.
Thomas Cerny active positions
| Companies | Position | Start |
|---|---|---|
University of St. Gallen
University of St. Gallen Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 21/06/2010 |
Swiss Cancer League | President | 12/01/2011 |
TOLREMO therapeutics AG
TOLREMO therapeutics AG Miscellaneous Commercial ServicesCommercial Services Develops and delivers therapies for treating cancer patients | Director/Board Member | - |
Proteomedix AG
Proteomedix AG BiotechnologyHealth Technology Operates as a private, commercial-stage diagnostics oncology company | Director/Board Member | - |
Former positions of Thomas Cerny
| Companies | Position | End |
|---|---|---|
THERAMetrics holding AG
THERAMetrics holding AG Pharmaceuticals: MajorHealth Technology Discovers drugs for patients suffering from rare diseases | Director/Board Member | 26/05/2011 |
Training of Thomas Cerny
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
THERAMetrics holding AG
THERAMetrics holding AG Pharmaceuticals: MajorHealth Technology Discovers drugs for patients suffering from rare diseases | Health Technology |
University of St. Gallen
University of St. Gallen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Bern
University of Bern Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swiss Cancer League | |
Proteomedix AG
Proteomedix AG BiotechnologyHealth Technology Operates as a private, commercial-stage diagnostics oncology company | Health Technology |
TOLREMO therapeutics AG
TOLREMO therapeutics AG Miscellaneous Commercial ServicesCommercial Services Develops and delivers therapies for treating cancer patients | Commercial Services |
- Stock Market
- Insiders
- Thomas Cerny
















